FDA Approved: VENTOLIN HFA — Supplemental Application (GlaxoSmithKline LLC)

View source ↗

Summary

FDA approved a supplemental application for Ventolin HFA (albuterol sulfate) from GlaxoSmithKline, expanding the labeling per the supplemental submission.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Chronic Obstructive Pulmonary Disease
• Exercise-induced Bronchoconstriction

Drugs mentioned

• VENTOLIN HFA (Albuterol sulfate)

Snippet

SUPPL AP for VENTOLIN HFA (ALBUTEROL SULFATE)